Bertrand David

Dr. Bertrand David

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
JGJérôme Vincent Grenier
Jérôme Vincent Grenier
HDHervé Duval
Hervé Duval
FBFabrice Barou
Fabrice Barou
PLPin Lv
Pin Lv
BDBertrand David
Bertrand David
Didier LetourneurDidier Letourneur
Didier Letourneur

16 August 2010 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
MDM. Deschepper
M. Deschepper
KOK. Oudina
K. Oudina
BDBertrand David
Bertrand David
VMV. Myrtil
V. Myrtil
CCC. Collet
C. Collet
Hervé PetiteHervé Petite
Hervé Petite
Use of mesenchymal stem cells (MSCs) has emerged as a potential new treatment for various diseases but has generated marginally successful results. A consistent finding of most studies is massive death of transplanted cells. The present study examined the respective roles of glucose and continuous severe hypoxia on MSC viability and function with respect to bone tissue engineering. We hereby demonstrate for the first time that MSCs survive exposure to long‐term (12 days), severe (pO2 < 1.5 mmHg) hypoxia, provided glucose is available. To this end, an in vitro model that mimics the hypoxic environment and cell‐driven metabolic changes encountered by grafted sheep cells was established. In this model, the hallmarks of hypoxia (low pO2, hypoxia inducible factor‐1α expression and anaerobic metabolism) were present. When conditions switched from hypoxic (low pO2) to ischemic (low pO2 and glucose depletion), MSCs exhibited shrinking, decreased cell viability and ATP content due to complete exhaustion of glucose at day 6; these results provided evidence that ischemia led to the observed massive cell death. Moreover, MSCs exposed to severe, continuous hypoxia, but without any glucose shortage, remained viable and maintained both their in vitro proliferative ability after simulation with blood reperfusion at day 12 and their in vivo osteogenic ability. These findings challenge the traditional view according to which severe hypoxia per se is responsible for the massive MSC death observed upon transplantation of these cells and provide evidence that MSCs are able to withstand exposure to severe, continuous hypoxia provided that a glucose supply is available.

1 February 2006 in Biomaterials
Verified
Journal Article
Closed access
ELEric Leclerc
Eric Leclerc
BDBertrand David
Bertrand David
LGL. Griscom
L. Griscom
Bruno Le PioufleBruno Le Pioufle
Bruno Le Pioufle
TFT. Fujii
T. Fujii
CLC. Legallaisa
C. Legallaisa

15 December 2009 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
SCSam M. Coward
Sam M. Coward
CLCecile Legallais
Cecile Legallais
BDBertrand David
Bertrand David
MTMichael Thomas
Michael Thomas
YFYing Foo
Ying Foo
CSClare Selden
Clare Selden

1 January 2001 in Journal of Membrane Science
Verified
Journal Article
Closed access
CLCecile Legallais
Cecile Legallais
BDBertrand David
Bertrand David
EDEmmanuel Dore
Emmanuel Dore

6 August 2004 in Biotechnology Progress
Verified
Journal Article
Closed access
BDBertrand David
Bertrand David
MDMurielle Dufresne
Murielle Dufresne
MNMarie‐Danielle Nagel
Marie‐Danielle Nagel
CLCecile Legallais
Cecile Legallais
In the present in vitro model, the authors intended to assess viability and functionality of hepatocytes encapsulated into alginate beads and submitted to a fluidized bed motion in a bioreactor. Human immortalized C3A line was chosen as cell model. Two controls consisting of (1) cells cultured on flasks and (2) cells encapsulated in alginate beads under static conditions were implemented. The cell functions studied were total protein, albumin, urea, and ammonia synthesis, as well as ammonia removal in the case of overdose. The comparison among the three cases studied showed that the three-dimensional structure of alginate offered a suitable environment for cell functions. In addition, the fluidized bed bioreactor enhanced the mass transfer and thus increased the amount of species released out of the beads, as compared with the static case. Ammonia detoxification only appeared reduced by encapsulation. The concept of a fluidized bed bioartificial liver was thus validated by this in vitro model, which indicated that cell functions could be efficiently retained. In addition, as far as urea and protein synthesis and release were concerned, the use of the C3A cell line, in combination with encapsulation and fluidization technology, offered a real potentiality for the purpose of extracorporeal liver supply.